Neurochemical study of mafoprazine, a new phenylpiperazine derivative.
スポンサーリンク
概要
- 論文の詳細を見る
Mafoprazine, a phenylpiperazine derivative, was neurochemically investigated in rats to determine its action mechanism. The rank order of affinity of mafoprazine for neuronal receptors was D<SUB>2</SUB>≥α<SUB>1</SUB>>S<SUB>2</SUB>>α<SUB>2</SUB> >> D<SUB>1</SUB>>β>mACh. The affinity of mafoprazine for D<SUB>2</SUB> receptors (K<SUB>i</SUB>=10.7 nM) was 2 times higher than that of azaperone, and 6 and 16 times lower than those of chlorpromazine and haloperidol, respectively, whereas the D<SUB>2</SUB> receptor selectivity [D<SUB>1</SUB>/D<SUB>2</SUB> (K<SUB>i</SUB> value ratio)] of mafoprazine was 10, 9 and 2 times higher than those of chlorpromazine, azaperone and haloperidol, respectively. The affinity of mafoprazine for α<SUB>2</SUB> receptors in terms of the ratio of the K<SUB>i</SUB> values for D<SUB>2</SUB> and α<SUB>2</SUB> receptors (D<SUB>2</SUB>/α<SUB>2</SUB>) was 345, 26 and 3 times higher than those of haloperidol, chlorpromazine and azaperone, respectively. Mafoprazine slightly showed the inhibitory effect on dopamine-stimulated adenylate cyclase (IC50=52300 nM), and it had almost no affinity for β and mACh receptors. Mafoprazine significantly increased dopamine metabolites in the corpus striatum and nucleus accumbens, although to lesser extents as compared with azaperone and chlorpromazine. These results suggest that mafoprazine probably manifests its antipsychotic action mainly through D<SUB>2</SUB> receptor blocking activity and α-adrenergic activity (α<SUB>1</SUB> receptor blocking activity and α<SUB>2</SUB> receptor stimulating activity).
- 公益社団法人 日本薬理学会の論文
著者
-
ISHIDA Ryuichi
Pharmacological Research Laboratory Tanabe Seiyaku Co., Ltd.
-
Matsuoka Yuzo
Pharmacology Department Discovery Research Laboratory Tanabe Seiyaku Co. Ltd.
-
FUKUCHI Isao
Pharmaceutical Development Research Laboratory, Tanabe Seiyaku Co., Ltd.
-
KAWASHIMA Kazutaka
Pharmacology Department, Safety Research Laboratory, Tanabe Seiyaku Co., Ltd.
関連論文
- Effects of Long-Term Administration of (4S)-1-Methyl-3-{(2S)-2-[N-((1S)-1-ethoxycarbonyl-3-phenylpropyl) amino] propionyl}-2-oxoimidazolidine-4-carboxylic Acid Hydrochloride (TA-6366), a New Angiotensin I Converting Enzyme (ACE) Inhibitor, from the Pre-hy
- Metabolic Abnormalities Caused by 3-Acetylpyridine in the Cerebral Motor Regions of Rats: Partial Recovery by Thyrotropin-Releasing Hormone
- Effect of TA-0910, a Novel Thyrotropin-Releasing Hormone Analog, on In Vivo Acetylcholine Release and Turnover in Rat Brain
- Anti-apoptotic Effect of Acetyl-l-carnitine and l-Carnitine in Primary Cultured Neurons
- Effects of mafoprazine, a phenylpiperazine derivative, on the central dopaminergic system.
- Reduction of the Mortality Rate by Imidapril in a Small Coronary Artery Disease Model, (NZW*BXSB)F1 Male Mice.
- A behavioral pharmacological study of mafoprazine, a new phenylpiperazine derivative.
- Neurochemical study of mafoprazine, a new phenylpiperazine derivative.
- Influence of Imidapril on Abnormal Biochemical Parameters in Salt-Loaded Stroke-Prone Spontaneously Hypertensive Rats(SHRSP).
- No Relation of the Suppressive Effect on the Sympathetic Nervous System to the Acute Hypotension Caused by Imidapril and Enalapril.